Abstract:The hepatitis C virus (HCV) core protein is a multifunctional protein that can interfere with the induction of an immune response. It has been reported that the HCV core protein inhibits HBV replication in vitro. In this study, we test the effect of the HCV core gene on the priming of the immune response to hepatitis B surface antigen (HBsAg) and on the replication of HBV in vivo. Our results showed that the full-length HCV core gene inhibits the induction of an immune response to the heterogeneous antigen, HBsAg, at the site of inoculation when HCV core (pC191) and HBsAg (pHBsAg) expression plasmids are co-administered as DNA vaccines into BALB/c mice. The observed interference effect of the HCV core occurs in the priming stage and is limited to the DNA form of the HBsAg antigen, but not to the protein form. The HCV core reduces the protective effect of the HBsAg when the HBsAg and the HCV core are co-administered as vaccines in an HBV hydrodynamic mouse model because the HCV core induces immune tolerance to the heterogeneous HBsAg DNA antigen. These results suggest that HCV core may play an important role in viral persistence by the attenuation of host immune responses to different antigens. We further tested whether the HCV core interfered with the priming of the immune response in hepatocytes via the hydrodynamic co-injection of an HBV replication-competent plasmid and an HCV core plasmid. The HCV core inhibited HBV replication and antigen expression in both BALB/c (H-2d) and C57BL/6 (H-2b) mice, the mouse models of acute and chronic hepatitis B virus infections. Thus, the HCV core inhibits the induction of a specific immune response to an HBsAg DNA vaccine. However, HCV C also interferes with HBV gene expression and replication in vivo, as observed in patients with coinfection.

Inhibition of Hepatitis C Virus Production by Aptamers Against the Core Protein.

Inhibition of hepatitis C virus infection by DNA aptamer against envelope protein

Inhibition of hepatitis C virus infection by NS5A-specific aptamer.

Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein

Inhibition of hepatitis C virus serine protease in living cells by RNA aptamers detected using fluorescent protein substrates

An Aptamer Targets Hbv Core Protein And Suppresses Hbv Replication In Hepg2.2.15 Cells

Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication in Vivo.

Construction and expression of plasmids containing the truncated core protein of different quasispecies genotype 1b hepatitis C virus

Effects on HepG2 cells growth of the different domains of genotype 1b hepatitis C virus core proteins

Inhibition of hepatits B virus (HBV) transcription and replication by HCV core protein in vitro

Network based analysis of hepatitis C virus core and NS4B protein interactions

Differential research of the seven different prokaryotic expression plasmid expressing the CORE protein of hepatitis C

Single-domain intrabodies against hepatitis C virus core inhibit viral propagation and core-induced NFκB activation

Hepatitis C Virus Core Protein Potentiates Proangiogenic Activity of Hepatocellular Carcinoma Cells

Selection of Rna Aptamers That Bind Specifically to the Ns3 Protease of Hepatitis C Virus

Core-Apobec3c Chimerical Protein Inhibits Hepatitis B Virus Replication

Functional Selection of Hepatitis C Virus Envelope E2-Binding Peptide Ligands by Using Ribosome Display

Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization

Identification Of Peptides That Bind Hepatitis C Virus Envelope Protein E2 And Inhibit Viral Cellular Entry From A Phage-Display Peptide Library

Intracellular-Delivery Of A Single-Chain Antibody Against Hepatitis B Core Protein Via Cell-Penetrating Peptide Inhibits Hepatitis B Virus Replication In Vitro

Construction and Gene Immunization of Recombinant Expression Plasmid of Hepatitis C Virus Core Gene